{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:20:39Z","timestamp":1788067239693,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To assess the predictive capabilities of serum exosomal levels of micro-RNA-520a-5p (miR-520a-5p) concerning the occurrence of severe preeclampsia (sPE) and fetal growth restriction (FGR) during the first trimester of pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>During the period spanning from October 2020 to October 2021, serum samples were procured from the first trimester and subsequently preserved by freezing at \u221280 \u2103. These samples were obtained from 105 pregnant women in a nested case\u2013control study. This cohort consisted of individuals who later developed sPE (sPE group, n = 35) and FGR (FGR group, n = 35) during the third trimester. Additionally, 35 women with normal blood pressure were denoted as normal pregnancy group. Serum samples from the first trimester were retrieved from all groups for further analysis after thawing. Exosomes were extracted from the serum samples collected during the first trimester and examined using transmission electron microscopy, western blot, and nanoparticle tracking analysis. Additionally, the determination of their placental origin was also established during the course of the study. Exosome miR-520a-5p levels were measured using real-time quantitative polymerase chain reaction assays, primarily involving quantitative reverse transcription polymerase chain reactions. Fetal placental tissues from the 3 groups were collected shortly after birth, and miR-520a-5p expression was measured using real-time quantitative polymerase chain reaction. Serum placental exosomes and fetal placental tissues were compared for miR-520a-5p levels. Placental trophoblasts were identified as the source of serum exosomes in all 3 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      It was found that serum placental exosomes exhibited lower levels of miR-520a-5p in both the sPE and FGR groups when compared to the normal pregnancy group. This finding was consistent with observations made in postpartum placental tissues. The predictive accuracy for sPE using miR-520a-5p levels in serum placental exosomes during the first trimester was notably higher (area under the receiver operating characteristic curve = 0.806,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05) compared to the prediction of FGR (area under the receiver operating characteristic curve = 0.628,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Placenta-derived exosomes can be extracted from maternal serum during the first trimester of pregnancy and miR-520a-5p detected from the exosomes. The downregulation of miR-520a-5p serves as a more predictive indicator for the subsequent development of sPE compared to predicting FGR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000038188","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:48:19Z","timestamp":1715996899000},"page":"e38188","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Prediction of severe preeclampsia and intrauterine growth restriction based on serum placental exosome miR-520a-5p levels during the first-trimester"],"prefix":"10.1097","volume":"103","author":[{"given":"Xin-Ran","family":"Xu","sequence":"first","affiliation":[{"name":"Obstetrics Department of Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China"},{"name":"NanKai University Affiliated Maternity Hospital, Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4641-2406","authenticated-orcid":false,"given":"Lan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Obstetrics Department of Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China"},{"name":"NanKai University Affiliated Maternity Hospital, Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Obstetrics Department of Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China"},{"name":"NanKai University Affiliated Maternity Hospital, Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1080\/14767058.2019.1581522","article-title":"Preeclampsia outcomes at delivery and race.","volume":"33","author":"Gyamfi-Bannerman","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice.","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000506804","article-title":"There is a strong association between early preeclampsia and congenital heart defects: a large population-based, retrospective study.","volume":"86","author":"Liu","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"R4-20250503","first-page":"361","article-title":"Expert consensus on fetal growth restriction (2019 edition).","volume":"22","year":"2019","journal-title":"Chin J Perinat Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.siny.2017.11.004","article-title":"Screening for fetal growth restriction and placental insufficiency.","volume":"23","author":"Audette","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000519954","article-title":"Evaluation of fetal renal artery Doppler indices in pregnancies complicated with preeclampsia.","volume":"86","author":"Kaya","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"R7-20250503","first-page":"36","article-title":"Analysis of varying MicroRNAs as a novel biomarker for early diagnosis of preeclampsia: a scoping systematic review of the observational study.","volume":"14","author":"Zhafir Asyura","year":"2023","journal-title":"Int J Prev Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"e0171756","DOI":"10.1371\/journal.pone.0171756","article-title":"First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.","volume":"12","author":"Hromadnikova","year":"2017","journal-title":"PLoS One"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-7498-6_6","article-title":"Epigenetics and preeclampsia: programming of future outcomes.","volume":"1710","author":"Peixoto","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000515086","article-title":"Tissue transglutaminase impairs HTR-8\/SVneo trophoblast cell invasion via the PI3K\/AKT signaling pathway.","volume":"86","author":"Cheng","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000513401","article-title":"Effect of IL-15-mediating IFN-\u03b3 on HTR-8\/SVneo cells and a preeclampsia mouse model induced by lipopolysaccharides.","volume":"86","author":"Wang","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000530006","article-title":"Expression of HMGB1-TLR4 in placentas from preeclamptic pregnancies and its effect on proliferation and invasion of HTR-8\/SVneo cells.","volume":"88","author":"He","year":"2023","journal-title":"Gynecol Obstet Invest"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000509161","article-title":"Altered expressions of AQP3 and ADP are closely related with the risk of preeclampsia occurrence.","volume":"85","author":"Zhou","year":"2020","journal-title":"Gynecol Obstet Invest"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1159\/000501254","article-title":"Early-pregnancy circulating antioxidant capacity and hemodynamic adaptation in recurrent placental syndrome: an exploratory study.","volume":"84","author":"Severens-Rijvers","year":"2019","journal-title":"Gynecol Obstet Invest"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000519371","article-title":"Soluble endoglin and uterine artery flow Doppler ultrasonography as markers of progression to preeclampsia in women with gestational hypertension.","volume":"86","author":"Molina P\u00e9rez","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"R17-20250503","first-page":"346","article-title":"Obstetrical medication: analysis of key points of aspirin prevention of preeclampsia.","volume":"38","author":"Zhou","year":"2022","journal-title":"J Appl Obstet Gynecol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3390\/cells11152428","article-title":"Non-coding RNAs and prediction of preeclampsia in the first trimester of pregnancy.","volume":"11","author":"Ogoyama","year":"2022","journal-title":"Cells"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.3390\/ijms20122972","article-title":"The prediction of gestational hypertension, preeclampsia and fetal growth restriction via the first trimester screening of plasma exosomal C19MC microRNAs.","volume":"20","author":"Hromadnikova","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.placenta.2020.09.069","article-title":"Transgenic expression of human C19MC miRNAs impacts placental morphogenesis.","volume":"101","author":"Mouillet","year":"2020","journal-title":"Placenta"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1007\/s13277-014-2138-z","article-title":"MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.","volume":"35","author":"Kaymaz","year":"2014","journal-title":"Tumour Biol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"e24347","DOI":"10.1002\/jcla.24347","article-title":"Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p\/KRT5 axis.","volume":"36","author":"Chen","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/genes13060938","article-title":"Exosomal miRNA profile in small-for-gestational-age children: a potential biomarker for catch-up growth.","volume":"13","author":"Jeong","year":"2022","journal-title":"Genes (Basel)"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000527078","article-title":"Downregulation of Circ_0088196 contributes to the development of trophoblastic cells through miR-133b sponging function to affect the AHNAK expression.","volume":"87","author":"Shi","year":"2022","journal-title":"Gynecol Obstet Invest"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.placenta.2022.02.005","article-title":"Contribution of vascular smooth muscle cell apoptosis to spiral artery remodeling in early human pregnancy.","volume":"120","author":"Liu","year":"2022","journal-title":"Placenta"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:07:07Z","timestamp":1746302827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":24,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038188","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}